
Hyperlipidemic agent that elevates plasma HDL and lowers triglycdrides and LDL by stabilizing apoA-I mRNA transcripts. Inhibits inducible nitric oxide synthase (iNOS; NOS II) by inhibiting the activation of NF-κB, activator protein-1 and CCAAT/enhancer-binding protein β.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|